1. Harnessing drug/radiation interaction through daily routine practice: Leverage medical and methodological point of view (MORSE 02-17 study). Issue 3 (December 2018) Authors: Vallard, A.; Rancoule, C.; Espenel, S.; Garcia, M.-A.; Langrand-Escure, J.; He, M.Y.; Ben Mrad, M.; El Meddeb Hamrouni, A.; Ouni, S.; Trone, J.-C.; Rehailia-Blanchard, A.; Guillaume, E.; Vial, N.; Riocreux, C.; Guy, J.-B.; Magné, N. Journal: Radiotherapy and oncology Issue: Volume 129:Issue 3(2018) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study). Issue 8 (August 2015) Authors: Rivoirard, R.; Falk, A.T.; Chargari, C.; Guy, J.-B.; Mery, B.; Nuti, C.; Peoc'h, M.; Forest, F.; Garin, C.; Adjabi, A.; Hoarau, D.; Kawaye, S.; Almokhles, H.; Fournel, P.; Magné, N. Journal: Clinical oncology Issue: Volume 27:Issue 8(2015) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-22: Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study. Issue 213 (May 2022) Authors: Daguenet, E.; Maison, M.; Tinquaut, F.; Giroux, E.-A.; Bertoletti, L.; Suchaud, J.-P.; Rancoule, C.; Guy, J.-B.; Magné, N. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗